Title:
DIRECT COMPRESSED ACTIVATED CARBON TABLET FORMULATION
Document Type and Number:
WIPO Patent Application WO/2021/134482
Kind Code:
A1
Abstract:
The present disclosure discloses a direct compressed enterosorbent tablet formulation comprising activated carbon and a binder, wherein the activated carbon is in the form of granules obtained from pitch or a polymer and wherein the binder is selected from microcrystalline cellulose, lactose, starch or combinations thereof and wherein the binder content is at least 33 % by weight. Also disclosed is a method of producing enterosorbent tablets.
Inventors:
DENG WANDING (CN)
ZOU MISHA (CN)
ZOU MISHA (CN)
Application Number:
PCT/CN2019/130517
Publication Date:
July 08, 2021
Filing Date:
December 31, 2019
Export Citation:
Assignee:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE)
FRESENIUS MEDICAL CARE R&D SHANGHAI CO LTD (CN)
FRESENIUS MEDICAL CARE R&D SHANGHAI CO LTD (CN)
International Classes:
A61K33/44; A61K9/20; A61P1/00
Foreign References:
| JP2005187405A | 2005-07-14 | |||
| RU2228186C1 | 2004-05-10 | |||
| CN103491949A | 2014-01-01 | |||
| CN1406587A | 2003-04-02 | |||
| CN1114195A | 1996-01-03 |
Attorney, Agent or Firm:
NTD PATENT AND TRADEMARK AGENCY LTD. (CN)
Download PDF:
Previous Patent: SOLUBLE SUPPORT MATERIALS FOR ADDITIVE MANUFACTURING
Next Patent: SUSPENSION CABLE STRUCTURE AND LIGHTING DEVICE
Next Patent: SUSPENSION CABLE STRUCTURE AND LIGHTING DEVICE